Sandy Liu, M.D.
Sandy Liu, M.D., has made it her mission to improve the lives of cancer patients by taking care of people in a meaningful way and advancing the field of medical oncology as a clinical researcher. She makes sure to treat all of her patients as though they were members of her own family.
Dr. Liu earned her medical degree from the George Washington University School of Medicine. During her final year, she participated in a medical mission to rural China, where she performed cardiovascular screening and distributed medications. She completed an internal medicine residency at Cedars-Sinai Medical Center and West Los Angeles VA Medical Center. Dr. Liu’s fellowship training in oncology/hematology was completed at UCLA, where she served as chief fellow during her final year and transitioned to roles as clinical instructor and, more recently, assistant clinical professor.
At City of Hope Orange County, her specialties include cancers of the kidney, prostate, bladder, testicles and urethra. Her research interests include immunotherapy and drug development.
Fluent in Mandarin Chinese, Dr. Liu enjoys free time spent hiking, riding her bike, reading, dining out and traveling.
- American Board of Internal Medicine
-
1999-2003, B.S., Biological Science, Gerontology Minor, University of Southern California, Los Angeles, CA
-
2007-2011, M.D., George Washington University, School of Medicine, Washington, DC
-
2014-2017, Hematology-Oncology, University of Southern California – Los Angeles, CA
-
2011-2014, Internal Medicine Internship and Residency University of Southern California, Los Angeles, CA
- 2020-2022, HS Assistant Professor, David Geffen School of Medicine at UCLA, Los Angeles, CA
- 2017-2019, HS Clinical Instructor, David Geffen School of Medicine at UCLA, Los Angeles, CA
- 2016-2017, Chief Fellow, David Geffen School of Medicine at UCLA, Los Angeles, CA
- 2017-2019, Fellow, David Geffen School of Medicine at UCLA, Los Angeles, CA
- American Society Clinical Oncology
- Liu ST, Pham H , Pandol SJ, Ptasznik A. Src as the link between inflammation and cancer. Front Physiol. 2014 Jan 16;4:416.
- Wirtschafter E, Walts AE, Liu ST, Marchevsky AM. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence. Lung. 2015 Oct;193(5):659-67.
- Liu ST, Cadaneanu RM, Zhang B, et al. Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone. PLOS One. 2016 Oct 6;11(10).
- Paymaneh M, Morikado M, Welter L, Liu ST, Miller E, Cadaneanu R, Knudsen B, Lewis M, Carlsson A, Ruiz V, Kolatkar A, Rodriguez-Lee M, Garraway I, Hicks J, Kuhn P. Clonal diversity revealed by morphoproteomic and copy number profiles of single prostate cancer cells at diagnosis. 2018 Converg. Sci. Phys. Oncol. 4 015003.
- Wang C, Raldow AC, Nickols NG, Nguyen PL, Spratt DE, Dess RT, Yu JR, King CR, Chu FI, Chamie K, Litwin MS, Saigal CS, Reiter RE, Liu ST, Rettig MB, Chang AJ, Steinberg ML, Kupelian. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High Grade Prostate Cancer. 2019 Journal European Urology.
- Khaki AR, Li A, Diamantopoulos LN, Bilen M, Santos V, Esther J, Morales R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Assi H, Gartrell B, Rodriguez-Vida A, Lythgoe M, Drakaki A, Joshi M, Velho P, Hahn N, Liu ST, Alonso L, Duran I Moses M, Murgic J, Baratam J, Barata P, Tripathi A, Galsky M, Sonpavde G, Yu E, Shankaran V, Lyman GH, Grivas P. Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with checkpoint inhibitors Cancer.
- Suarez-Sarmiento A Jr, Nguyen KA, Syed JS, Nolte A, Ghabili K, Cheng M, Liu S, Chiang V, Kluger H, Hurwitz M, Shuch B. Brain Metastasis From Renal-Cell Carcinoma: An Institutional Study. Clin Genitourin Cancer. 2019 Dec;17(6):e1163-e1170. doi: 10.1016/j.clgc.2019.08.006. Epub 2019 Aug 20. PMID: 31519468
- Kishan AU, Chu FI, King CR, Seiferheld W, Spratt DE, Tran P, Wang X, Pugh SE, Sandler KA, Bolla M, Maingon P, De Reijke T, Nickols NG, Rettig M, Drakaki A, Liu ST, Reiter RE, Chang AJ, Feng FY, Sajed D, Nguyen PL, Kupelian PA, Steinberg ML, Boutros PC, Elashoff D, Collette L, Sandler HM. Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. Eur Urol. 2020 Feb;77(2):201-208. doi: 10.1016/j.eururo.2019.10.008. Epub 2019 Nov 10. PMID: 31718822
- Miller NJ, Khaki AR, Diamantopoulos LN, Bilen MA, Santos V, Agarwal N, Morales-Barrera R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Assi H, Gartrell BA, Sankin A, Rodriguez-Vida A, Lythgoe M, Pinato DJ, Drakaki A, Joshi M, Isaacsson Velho P, Hahn N, Liu S, Alonso Buznego L, Duran I, Moses M, Jain J, Murgic J, Barata P, Tripathi A, Zakharia Y, Galsky MD, Sonpavde G, Yu EY, Lyman GH, Grivas P. Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study. J Urol. 2020 Jul;204(1):63-70. doi: 10.1097/JU.0000000000000761. Epub 2020 Jan 23. PMID: 31971495.
- Liu S, Shuch B. Genetic Testing in Kidney Cancer Patients: Who, When, and How? Eur Urol Focus. 2019 Nov;5(6):973-976. doi: 10.1016/j.euf.2019.09.005. Epub 2019 Oct 6.
- Hotta M, Sonni I, Benz, Bahri S, Shuch BM, Yu R, Liu ST, Czernin J, Calais J. 68 Ga-FAPI-46 and 18 F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors. ur J Nucl Med Mol Imaging . 2021 Oct;48(11):3736-3737. doi: 10.1007/s00259-021-05373-5. Epub 2021 Apr 29.
- Campagna G, Liu ST, Tsui E. Trichomegaly and Trichiasis Associated with Pemigatinib. Ophthalmology. 2021 Sep;128(9):1364. doi: 10.1016/j.ophtha.2021.02.022.
- Miller NJ, Khaki AR, Diamantopoulos LN, Bilen MA, Liu ST, et al. Histologic Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer. The Journal of Urology. https://doi.org/10.1097/JU.0000000000000761